FindTrial
Sign In

Primary malignant perivascular epithelioid cell tumor of bone with TFE3 rearrangement: case report

Primary malignant perivascular epithelioid cell tumor of bone with TFE3 rearrangement: case report

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080506
Enrollment
Unknown
Registered
2024-01-31
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perivascular epithelioid cell tumor

Interventions

Observation group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
54 Years to 54 Years

Inclusion criteria

Inclusion criteria: Primary malignant perivascular epithelioid cell tumor of bone with TFE3 rearrangement

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
progression-free survival,;—

Secondary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactHong Duan

West China Hospital, Sichuan University

duanhong1970@126.com+86 189 8060 1402

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026